PL2691119T3 - Preparat farmaceutyczny - Google Patents

Preparat farmaceutyczny

Info

Publication number
PL2691119T3
PL2691119T3 PL12719996T PL12719996T PL2691119T3 PL 2691119 T3 PL2691119 T3 PL 2691119T3 PL 12719996 T PL12719996 T PL 12719996T PL 12719996 T PL12719996 T PL 12719996T PL 2691119 T3 PL2691119 T3 PL 2691119T3
Authority
PL
Poland
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
PL12719996T
Other languages
English (en)
Inventor
Ian Cottingham
Daniel Plaksin
Jenny AHARANOV
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL2691119T3 publication Critical patent/PL2691119T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12719996T 2011-03-31 2012-03-29 Preparat farmaceutyczny PL2691119T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11160736 2011-03-31
EP12151389 2012-01-17
EP12719996.6A EP2691119B1 (en) 2011-03-31 2012-03-29 Pharmaceutical preparation
PCT/GB2012/000291 WO2012131306A1 (en) 2011-03-31 2012-03-29 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
PL2691119T3 true PL2691119T3 (pl) 2019-01-31

Family

ID=46051700

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12719996T PL2691119T3 (pl) 2011-03-31 2012-03-29 Preparat farmaceutyczny

Country Status (8)

Country Link
US (1) US9757469B2 (pl)
EP (1) EP2691119B1 (pl)
JP (2) JP6087338B2 (pl)
CN (1) CN103619358B (pl)
CA (2) CA2831486A1 (pl)
ES (1) ES2693273T3 (pl)
PL (1) PL2691119T3 (pl)
WO (1) WO2012131306A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012131306A1 (en) * 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
EP3434686B1 (en) * 2016-03-22 2025-10-01 Universidade de São Paulo - USP Method for producing and purifying hybrid or non-hybrid recombinant glycoprotein hormones, hybrid or non-hybrid recombinant glycoprotein hormones, expression vectors and uses of the recombinant glycoprotein hormones

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4421896A (en) * 1979-11-13 1983-12-20 The Dow Chemical Company Method of coupling a protein to a polymer particle containing hydrazide groups in a polymer latex and the products formed therefrom
DK49987A (da) 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
BR9810478A (pt) 1997-06-25 2000-09-12 Applied Research Systems Análogos de hormÈnio glicoproteìna reticulados por dissulfeto e sua preparação e utilização
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
JP4588960B2 (ja) 2000-02-22 2010-12-01 メルク セローノ ソシエテ アノニム hCGの精製方法及び本法により精製した組換えhCG
EP1425032A2 (en) 2001-09-12 2004-06-09 Applied Research Systems ARS Holding N.V. USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
UA87433C2 (ru) 2001-10-22 2009-07-27 Еплайд Рісьорч Системз Ерс Холдінг Н.В. Гонадотропины для стимулирования фолликулогенеза
CN100347306C (zh) 2001-10-29 2007-11-07 克鲁塞尔荷兰公司 生产具有预定的翻译后修饰的蛋白质的方法和手段
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
EP1711834B1 (en) 2004-02-04 2010-08-04 Centre National De La Recherche Scientifique Process for screening glycoform-specific antibodies
EP1725673A1 (en) * 2004-02-13 2006-11-29 Glycotope Gmbh Sialytated glycoproteins-process conditions and an efficient method for their production
US20080242607A1 (en) * 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
BRPI0717505B8 (pt) 2006-10-04 2021-05-25 Novo Nordisk As conjugado de peptídeo e formulação farmacêutica
JP5647899B2 (ja) * 2008-01-08 2015-01-07 ラツィオファルム ゲーエムベーハーratiopharm GmbH オリゴサッカリルトランスフェラーゼを使用するポリペプチドの複合糖質化
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012131306A1 (en) * 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation

Also Published As

Publication number Publication date
US20140088010A1 (en) 2014-03-27
EP2691119A1 (en) 2014-02-05
JP2017101030A (ja) 2017-06-08
WO2012131306A1 (en) 2012-10-04
US9757469B2 (en) 2017-09-12
CN103619358B (zh) 2017-02-15
JP6336557B2 (ja) 2018-06-06
CA2831486A1 (en) 2012-10-04
CA3163525A1 (en) 2012-10-04
WO2012131306A8 (en) 2013-10-24
CN103619358A (zh) 2014-03-05
JP6087338B2 (ja) 2017-03-01
EP2691119B1 (en) 2018-08-01
JP2014510745A (ja) 2014-05-01
ES2693273T3 (es) 2018-12-10

Similar Documents

Publication Publication Date Title
AP3864A (en) Pharmaceutical composition
PL2776416T3 (pl) Związki farmaceutyczne
SG10201604667YA (en) Pharmaceutical preparation
ZA201307372B (en) Coated solid pharmaceutical preparation
GB201118232D0 (en) Pharmaceutical composition
AP2014007498A0 (en) Pharmaceutical compositions
IL232305A0 (en) pharmaceutical preparations
ZA201308157B (en) Pharmaceutical composition
GB201119799D0 (en) Pharmaceutical compounds
ZA201403832B (en) Pharmaceutical compounds
GB201105298D0 (en) Pharmaceutical preparation
GB201118876D0 (en) Pharmaceutical compounds
GB201113163D0 (en) Pharmaceutical compounds
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition
HUP1100445A2 (en) Pharmaceutical composition
GB201119796D0 (en) Pharmaceutical comopounds
GB201120735D0 (en) New pharmaceutical uses
GB201111577D0 (en) Pharmaceutical formulations
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
PL390620A1 (pl) Preparat farmaceutyczny
GB201117359D0 (en) Pharmaceutical compounds
GB201105026D0 (en) Pharmaceutical compounds
GB201118874D0 (en) Pharmaceutical compounds